These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6341349)

  • 1. Comparative activity of cefotetan on Escherichia coli K12 possessing plasmid-mediated beta-lactamases.
    Chabbert YA; Derlot E
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():159-67. PubMed ID: 6341349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibiotics.
    Neu HC; Chin NX
    Chemioterapia; 1985 Aug; 4(4):271-7. PubMed ID: 3876887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefotetan: profile of in-vitro activity.
    Bauernfeind A
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():19-29. PubMed ID: 6601656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of cefotetan and other cephalosporins against multiresistant strains of Enterobacteriaceae.
    Leigh DA; Marriner J
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():103-5. PubMed ID: 6573310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefotetan: comparative study in vitro against 226 Gram-negative clinical isolates.
    Morel C; Vergnaud M; Langeard MM; Dupuy L
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():31-6. PubMed ID: 6573323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative susceptibilities of organisms isolated in Sicily to cefotetan and other antibiotics.
    Russo G; Gismondo MR; Toscano MA; Speciale AM; Nicoletti G
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():79-85. PubMed ID: 6573327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.
    Jones RN; Wilson HW
    Diagn Microbiol Infect Dis; 1983 Mar; 1(1):71-83. PubMed ID: 6323095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibilities of gentamicin-resistant Gram-negative aerobic bacilli to cefotetan and other beta-lactams.
    Hart CA; Percival A
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():95-101. PubMed ID: 6573329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.
    Ayers LW; Jones RN; Barry AL; Thornsberry C; Fuchs PC; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1982 Nov; 22(5):859-77. PubMed ID: 6983862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefotetan: in-vitro antibacterial activity and susceptibility to beta-lactamases.
    Phillips I; King A; Shannon K; Warren C
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():1-9. PubMed ID: 6601650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
    Medeiros AA; Hare R; Papa E; Adam C; Miller GH
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefotetan activity against Gram-negative aerobes and anaerobes.
    Moosdeen F; Maskell J; Philpott-Howard J; Williams JD
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():59-65. PubMed ID: 6601657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefotetan and beta-lactamases. I. An analysis of the affinity of cefotetan for beta-lactamases.
    Labia R; Morand A; Verchere-Beaur C; Doré JC
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():147-52. PubMed ID: 6601654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefotetan: antimicrobial activity in-vitro compared with that of cefotaxime.
    Dette GA; Knothe H; Henckel S
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():11-7. PubMed ID: 6302064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative activity of cefotetan against plasmid-encoded aminoglycoside-resistant enterobacteria strains.
    Gomez-Lus R; Otal I; Gomez-Lus ML; Sarraseca C; Castillo J; Gil J; Rubio MC
    Chemioterapia; 1988 Aug; 7(4):267-70. PubMed ID: 3180307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro comparison of cefotetan with five other cephalosporins against nosocomial pathogens.
    Daschner FD; Goerke C; Bassler M; Just M
    Chemotherapy; 1982; 28(5):351-4. PubMed ID: 6958416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of the cephamycin cefotetan: an in-vitro comparison with other beta-lactam antibiotics.
    Clarke AM; Zemcov SJ
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():67-72. PubMed ID: 6404881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases.
    Raimondi A; Mattina R; Cocuzza CE
    Chemioterapia; 1988 Feb; 7(1):3-9. PubMed ID: 3288365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of bacterial pathogens to cefotetan judged by MIC and disc tests.
    Grimm H
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():37-43. PubMed ID: 6573324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.